AVTX
Avalo Therapeutics Inc.
$17.83
+$0.09(+0.51%)
71
Overall
80
Value
63
Tech
--
Quality
Market Cap
$281.44M
Volume
164.53K
52W Range
$3.39 - $19.41
Target Price
$35.33
Key Metrics Overview
| Market Cap | $281.44M | P/E Ratio | N/A |
| 52W High | $19.41 | 52W Low | $3.39 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 91.8% | 52W Position | 90.1% |
| Overall Score | 71 | Value Score | 80 |
| Quality Score | -- | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-6.93 | EPS Next Est | $-5.58 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $17.83 | +0.5% | 164.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |